CIK 0001088856 · Large accelerated filer
CORCEPT THERAPEUTICS INC
Sign in to watch- Ticker
- CORT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770487658
- Phone
- 650.688.8803
- Business address
- 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,067,988
- in 15 filings, $36.6M under 10b5-1 plans
Net −$41,067,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-15 | Mokari Atabak Chief Financial Officer | Sale 10b5-1 | −11,081 | $80.94 | $897K | 35,615 |
| 2026-06-15 | Mokari Atabak Chief Financial Officer | Sale 10b5-1 | −19,483 | $81.81 | $1.6M | 16,132 |
| 2026-06-15 | Mokari Atabak Chief Financial Officer | Sale 10b5-1 | −2 | $82.45 | $165 | 16,130 |
| 2026-06-15 | Mokari Atabak Chief Financial Officer | Option exercise · Stock option (right to buy) 10b5-1 | −40,000 | 20,000 | ||
| 2026-06-02 | Guyer William Chief Development Officer | Option exercise 10b5-1 | +20,000 | $21.65 | $433K | 23,985 |
| 2026-06-02 | Guyer William Chief Development Officer | Sale 10b5-1 | −20,000 | $70.60 | $1.4M | 3,985 |
| 2026-06-02 | Guyer William Chief Development Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −20,000 | 150,000 | ||
| 2026-06-02 | Lyon Joseph Douglas See Remarks | Shares withheld for taxes | −269 | $70.44 | $19K | 7,035 |
| 2026-06-02 | Maduck Sean See Remarks | Shares withheld for taxes 10b5-1 | −452 | $70.44 | $32K | 9,755 |
| 2026-06-02 | Mokari Atabak Chief Financial Officer | Shares withheld for taxes 10b5-1 | −395 | $70.44 | $28K | 16,130 |
| 2026-06-02 | Robb Gary Charles Chief Business Officer | Shares withheld for taxes | −358 | $70.44 | $25K | 25,681 |
| 2026-06-01 | Lyon Joseph Douglas See Remarks | Grant or award | +537 | $70.44 | $38K | 6,767 |
| 2026-06-01 | Lyon Joseph Douglas See Remarks | Grant or award | +537 | 7,304 | ||
| 2026-06-01 | Guyer William Chief Development Officer | Grant or award | +877 | $70.44 | $62K | 3,108 |
| 2026-06-01 | Guyer William Chief Development Officer | Grant or award | +877 | 3,985 | ||
| 2026-06-01 | Maduck Sean See Remarks | Option exercise 10b5-1 | +25,000 | $8.27 | $207K | 33,977 |
| 2026-06-01 | Maduck Sean See Remarks | Sale 10b5-1 | −21,069 | $70.11 | $1.5M | 12,908 |
| 2026-06-01 | Maduck Sean See Remarks | Sale 10b5-1 | −3,931 | $70.75 | $278K | 8,977 |
| 2026-06-01 | Maduck Sean See Remarks | Grant or award 10b5-1 | +615 | $70.44 | $43K | 9,592 |
| 2026-06-01 | Maduck Sean See Remarks | Grant or award 10b5-1 | +615 | 10,207 |
Page 9 of 61 · 1,220 trades